Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Research progresses of monoclonal antibodies therapy in neuromyelitis optica].
Differences in Body Composition Across Levels of Disability Among Ambulatory Patients Living With Multiple Sclerosis: 2569 Board #92 June 3, 9: 30 AM - 11: 00 AM.
Reduced Dual-Task Performance in MS Patients Is Further Decreased by Muscle Fatigue.
Intention tremor and deficits of sensory feedback control in multiple sclerosis: a pilot study.
The best clinical paper on multiple sclerosis in 2014: Herodotus and Chataway - Commentary.
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.
Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis.
Oligodendrocytes: Myelination and Axonal Support.
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.
Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis.
Off-pump coronary surgery in a patient with multiple sclerosis.
Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases.
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
The effectiveness of fingolimod in a Portuguese real-world population.
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.

Pages